Filing Details

Accession Number:
0000899243-18-031442
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-19 20:08:47
Reporting Period:
2018-12-17
Accepted Time:
2018-12-19 20:08:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501134 Invitae Corp NVTA Services-Medical Laboratories (8071) 271701898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1689575 Katherine Stueland C/O Invitae Corporation
1400 16Th Street
San Francisco CA 94103
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-17 1,000 $11.44 189,370 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on September 14, 2018.
  2. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
  3. Represents weighted average sale price. Actual sale prices ranged from $10.97 to $11.86.
  4. Includes an aggregate of 175,294 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.